HYPERTET

This brand name is authorized in United States. It is also authorized in Canada, Hong Kong SAR China, Singapore.

Active ingredients

The drug HYPERTET contains one active pharmaceutical ingredient (API):

1	Tetanus immunoglobulin UNII V4SWI4RF4J - HUMAN CLOSTRIDIUM TETANI TOXOID IMMUNE GLOBULIN
	Human tetanus immunoglobulin contains mainly immunoglobulin G (IgG) with a specifically high content of antibodies against the toxin produced by the bacteria clostridium tetanus.
	Read more about Tetanus immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
HYPERTET Solution for injection	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J06BB02	Tetanus immunoglobulin	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02230697
HK	Department of Health Drug Office	54930
SG	Health Sciences Authority	09656P
US	FDA, National Drug Code	13533-634